# Filing Detail

Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-25-052381
Filing Date
2025-05-23
Accepted
2025-05-23 15:27:47
Documents
72

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-1 | tm2415719-14_s1.htm | S-1 | 5399242
2 | EXHIBIT 3.1 | tm2415719d15_ex3-1.htm | EX-3.1 | 252538
3 | EXHIBIT 3.2 | tm2415719d15_ex3-2.htm | EX-3.2 | 103279
4 | EXHIBIT 3.3 | tm2415719d15_ex3-3.htm | EX-3.3 | 78147
5 | EXHIBIT 3.4 | tm2415719d15_ex3-4.htm | EX-3.4 | 159750
6 | EXHIBIT 4.2 | tm2415719d15_ex4-2.htm | EX-4.2 | 432392
7 | EXHIBIT 10.1(A) | tm2415719d15_ex10-1a.htm | EX-10.1(A) | 1519583
8 | EXHIBIT 10.1(B) | tm2415719d15_ex10-1b.htm | EX-10.1(B) | 81910
9 | EXHIBIT 10.2(A) | tm2415719d15_ex10-2a.htm | EX-10.2(A) | 213369
10 | EXHIBIT 10.2(B) | tm2415719d15_ex10-2b.htm | EX-10.2(B) | 81142
11 | EXHIBIT 10.3(A) | tm2415719d15_ex10-3a.htm | EX-10.3(A) | 499920
12 | EXHIBIT 10.3(B) | tm2415719d15_ex10-3b.htm | EX-10.3(B) | 413307
13 | EXHIBIT 10.3(C) | tm2415719d15_ex10-3c.htm | EX-10.3(C) | 521849
14 | EXHIBIT 10.4(A) | tm2415719d15_ex10-4a.htm | EX-10.4(A) | 183754
15 | EXHIBIT 10.4(B) | tm2415719d15_ex10-4b.htm | EX-10.4(B) | 76070
16 | EXHIBIT 10.4(C) | tm2415719d15_ex10-4c.htm | EX-10.4(C) | 73690
17 | EXHIBIT 10.4(D) | tm2415719d15_ex10-4d.htm | EX-10.4(D) | 78270
18 | EXHIBIT 10.4(E) | tm2415719d15_ex10-4e.htm | EX-10.4(E) | 64173
19 | EXHIBIT 10.4(F) | tm2415719d15_ex10-4f.htm | EX-10.4(F) | 69278
20 | EXHIBIT 10.4(G) | tm2415719d15_ex10-4g.htm | EX-10.4(G) | 69202
21 | EXHIBIT 10.5 | tm2415719d15_ex10-5.htm | EX-10.5 | 155865
22 | EXHIBIT 10.6 | tm2415719d15_ex10-6.htm | EX-10.6 | 105387
23 | EXHIBIT 10.7 | tm2415719d15_ex10-7.htm | EX-10.7 | 74103
24 | EXHIBIT 10.8 | tm2415719d15_ex10-8.htm | EX-10.8 | 16761
25 | EXHIBIT 10.9 | tm2415719d15_ex10-9.htm | EX-10.9 | 85631
26 | EXHIBIT 10.10 | tm2415719d15_ex10-10.htm | EX-10.10 | 19093
27 | EXHIBIT 10.11 | tm2415719d15_ex10-11.htm | EX-10.11 | 12280
28 | EXHIBIT 10.12 | tm2415719d15_ex10-12.htm | EX-10.12 | 98504
29 | EXHIBIT 16.1 | tm2415719d15_ex16-1.htm | EX-16.1 | 2449
30 | EXHIBIT 23.1 | tm2415719d15_ex23-1.htm | EX-23.1 | 1999
31 | EXHIBIT 23.2 | tm2415719d15_ex23-2.htm | EX-23.2 | 1985
32 | EXHIBIT 23.4 | tm2415719d15_ex23-4.htm | EX-23.4 | 16879
33 | EX-FILING FEES | tm2415719d15_ex-filingfees.htm | EX-FILING FEES | 21714
34 | GRAPHIC | bc_caris-4c.jpg | GRAPHIC | 97839
35 | GRAPHIC | bc_carispoanet-4c.jpg | GRAPHIC | 81557
36 | GRAPHIC | bc_casevolume-4c.jpg | GRAPHIC | 135027
37 | GRAPHIC | bc_novelcircul-4c.jpg | GRAPHIC | 104614
38 | GRAPHIC | bc_publications-4c.jpg | GRAPHIC | 190047
39 | GRAPHIC | fc_abcdaiassure-4c.jpg | GRAPHIC | 169224
40 | GRAPHIC | fc_centraldogma-4c.jpg | GRAPHIC | 65657
41 | GRAPHIC | fc_clinicalmole-4c.jpg | GRAPHIC | 220674
42 | GRAPHIC | fc_companion-4c.jpg | GRAPHIC | 120659
43 | GRAPHIC | fc_discovery-4c.jpg | GRAPHIC | 301384
44 | GRAPHIC | fc_keydevelop-4c.jpg | GRAPHIC | 93934
45 | GRAPHIC | fc_miprofile-4c.jpg | GRAPHIC | 263758
46 | GRAPHIC | fc_miprofile02-4c.jpg | GRAPHIC | 197502
47 | GRAPHIC | lc_colorectal-4c.jpg | GRAPHIC | 51461
48 | GRAPHIC | lc_oursolutions-4c.jpg | GRAPHIC | 108423
49 | GRAPHIC | lc_plasmabuffy-4c.jpg | GRAPHIC | 165820
50 | GRAPHIC | lc_significant-4c.jpg | GRAPHIC | 99531
51 | GRAPHIC | lg_carislifesciences-pn.jpg | GRAPHIC | 32014
52 | GRAPHIC | lg_datacliniclogo-4c.jpg | GRAPHIC | 267557
53 | GRAPHIC | pc_platform-4c.jpg | GRAPHIC | 163584
54 | GRAPHIC | pc_strategic-4c.jpg | GRAPHIC | 187809
55 | GRAPHIC | pc_unique-4c.jpg | GRAPHIC | 207999
56 | GRAPHIC | pc_unlocking-4c.jpg | GRAPHIC | 122347
57 | GRAPHIC | pg_bynumbers-4c.jpg | GRAPHIC | 344406
58 | GRAPHIC | pg_carislifesciences-4c.jpg | GRAPHIC | 517760
59 | GRAPHIC | pg_casevaluegrowth-4c.jpg | GRAPHIC | 142126
60 | GRAPHIC | pg_revenuegrowth-4c.jpg | GRAPHIC | 182132
61 | GRAPHIC | ph_cancercate-4c.jpg | GRAPHIC | 42981
62 | GRAPHIC | ph_powerofbigdata-4c.jpg | GRAPHIC | 57296
63 | GRAPHIC | tb_micancer-4c.jpg | GRAPHIC | 111254
64 | GRAPHIC | tb_micancerseek-4c.jpg | GRAPHIC | 98659
65 | GRAPHIC | tb_molecular-4c.jpg | GRAPHIC | 150107
66 | GRAPHIC | tb_panels-4c.jpg | GRAPHIC | 167453
67 | GRAPHIC | tb_technical-4c.jpg | GRAPHIC | 242325
68 | GRAPHIC | tm2415719d15_ex10-2aimg001.jpg | GRAPHIC | 1520
69 | GRAPHIC | tm2415719d15_ex10-2asp4img01.jpg | GRAPHIC | 2084
70 | GRAPHIC | tm2415719d15_ex10-3bsp2img2.jpg | GRAPHIC | 3389
71 | GRAPHIC | tm2415719d15_ex10-3bsp2img3.jpg | GRAPHIC | 7078
72 | GRAPHIC | tm2415719d15_ex10-3bsp4img1.jpg | GRAPHIC | 12812
| Complete submission text file | 0001104659-25-052381.txt |  | 18560616

Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Filer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-287551 | Film No.: 25981732
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)